Eglesia, Severina .

HRN: 21-95-68  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/13/2022
CEFTAZIDIME 1GM (VIAL)
10/13/2022
10/19/2022
IVT
1g
Q8
PTB, CAP-MR
Waiting Final Action 
10/14/2022
CIPROFLOXACIN 500MG (TAB)
10/14/2022
10/20/2022
PO
500mg
BID
CAP-MR; UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: